PL369953A1 - Polipeptydy zawierające glikozylofosfatydyloinozytol - Google Patents

Polipeptydy zawierające glikozylofosfatydyloinozytol

Info

Publication number: PL369953A1
Authority: PL; Poland
Prior art keywords: polypeptides; glycosylphosphatidylinositol; containing polypeptides; relates; domain
Prior art date: 2001-10-13

Application number

PL02369953A

Other languages

English (en)

Inventor

Richard Ross

Original Assignee

Asterion Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-13

Filing date

2002-10-11

Publication date

2005-05-02

2001-10-13 Priority claimed from GB0124620A external-priority patent/GB2380735A/en

2002-01-16 Priority claimed from GB0200904A external-priority patent/GB0200904D0/en

2002-08-14 Priority claimed from GB0218889A external-priority patent/GB0218889D0/en

2002-10-11 Application filed by Asterion Limited filed Critical Asterion Limited

2005-05-02 Publication of PL369953A1 publication Critical patent/PL369953A1/pl

Links

229920001184 polypeptide Polymers 0.000 title abstract 5
108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
229930004094 glycosylphosphatidylinositol Natural products 0.000 title abstract 3
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000005962 receptors Human genes 0.000 abstract 1
108020003175 receptors Proteins 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Transplantation (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Oncology (AREA)

PL02369953A 2001-10-13 2002-10-11 Polipeptydy zawierające glikozylofosfatydyloinozytol PL369953A1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0124620A GB2380735A (en)	2001-10-13	2001-10-13	GPI-anchored proteins
GB0200904A GB0200904D0 (en)	2002-01-16	2002-01-16	Anchors-2
GB0218889A GB0218889D0 (en)	2002-08-14	2002-08-14	Anchors 3

Publications (1)

Publication Number	Publication Date
PL369953A1 true PL369953A1 (pl)	2005-05-02

Family

ID=27256298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369953A PL369953A1 (pl)	2001-10-13	2002-10-11	Polipeptydy zawierające glikozylofosfatydyloinozytol

Country Status (17)

Country	Link
US (1)	US7485713B2 (pl)
EP (1)	EP1446733B1 (pl)
JP (1)	JP4384492B2 (pl)
KR (2)	KR20100039911A (pl)
CN (1)	CN1568330A (pl)
AT (1)	ATE442444T1 (pl)
AU (1)	AU2002334161B2 (pl)
CA (1)	CA2494706A1 (pl)
DE (1)	DE60233674D1 (pl)
DK (1)	DK1446733T3 (pl)
ES (1)	ES2329228T3 (pl)
HU (1)	HUP0401611A3 (pl)
IL (1)	IL161296A0 (pl)
NZ (1)	NZ532460A (pl)
PL (1)	PL369953A1 (pl)
PT (1)	PT1446733E (pl)
WO (1)	WO2003034275A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1943332A4 (en)	2005-10-14	2011-04-13	Medimmune Inc	CELLULAR DISPLAY OF ANTIBODY LIBRARIES
HUE039865T2 (hu) *	2005-12-20	2019-02-28	Sbi Biotech Co Ltd	Anti-ILT7 antitest
WO2007098547A1 (en) *	2006-03-01	2007-09-07	Apollo Life Sciences Limited	A molecule and chimeric molecules thereof
GB0618082D0 (en) *	2006-09-14	2006-10-25	Asterion Ltd	Growth factor
US20110076752A1 (en) *	2007-02-09	2011-03-31	Medimmune, Llc	Antibody library display by yeast cell plasma membrane
NZ602170A (en) *	2008-02-08	2014-03-28	Ambrx Inc	Modified leptin polypeptides and their uses
SG11201508433TA (en) *	2013-04-12	2015-11-27	Andaloussi Samir El	Therapeutic delivery vesicles
JP7083206B2 (ja)	2019-06-28	2022-06-10	国立大学法人東京大学	タンパク質内包高分子ミセル
CN120865355A (zh) *	2024-04-29	2025-10-31	苏州系统医学研究所	一种工程化改造gpi锚定信号肽、其融合蛋白及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5374548A (en) *	1986-05-02	1994-12-20	Genentech, Inc.	Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US4857637A (en) *	1986-05-07	1989-08-15	Genentech, Inc.	Methods and compositions for immunologically modulating growth hormone receptor activity
US5057417A (en) *	1987-06-12	1991-10-15	Genentech, Inc.	Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US6113917A (en) *	1995-04-25	2000-09-05	Rmf Dictagene S.A.	Modified polypeptides for enhanced immunogenicity
TW562807B (en)	1997-04-01	2003-11-21	Chugai Pharmaceutical Co Ltd	Novel secretory membrane protein
AU756759B2 (en) *	1997-06-26	2003-01-23	Immunex Corporation	Protein that binds trail
WO1999060113A1 (en) *	1998-05-20	1999-11-25	Chugai Seiyaku Kabushiki Kaisha	Novel method for isolating gene
AU3628800A (en)	1999-03-24	2000-10-09	Human Genome Sciences, Inc.	Human tumor necrosis factor receptor tr9
JP3815409B2 (ja) *	2002-08-29	2006-08-30	ブラザー工業株式会社	電話端末、通話システムおよび端末制御プログラム

2002
- 2002-10-11 PL PL02369953A patent/PL369953A1/pl unknown
- 2002-10-11 ES ES02801405T patent/ES2329228T3/es not_active Expired - Lifetime
- 2002-10-11 US US10/492,403 patent/US7485713B2/en not_active Expired - Fee Related
- 2002-10-11 WO PCT/GB2002/004665 patent/WO2003034275A2/en not_active Ceased
- 2002-10-11 JP JP2003536934A patent/JP4384492B2/ja not_active Expired - Lifetime
- 2002-10-11 DK DK02801405T patent/DK1446733T3/da active
- 2002-10-11 AU AU2002334161A patent/AU2002334161B2/en not_active Ceased
- 2002-10-11 CA CA002494706A patent/CA2494706A1/en not_active Abandoned
- 2002-10-11 CN CNA028202775A patent/CN1568330A/zh active Pending
- 2002-10-11 PT PT02801405T patent/PT1446733E/pt unknown
- 2002-10-11 NZ NZ532460A patent/NZ532460A/en not_active IP Right Cessation
- 2002-10-11 HU HU0401611A patent/HUP0401611A3/hu unknown
- 2002-10-11 KR KR1020107007082A patent/KR20100039911A/ko not_active Ceased
- 2002-10-11 DE DE60233674T patent/DE60233674D1/de not_active Expired - Lifetime
- 2002-10-11 AT AT02801405T patent/ATE442444T1/de not_active IP Right Cessation
- 2002-10-11 KR KR1020047005419A patent/KR20050035511A/ko not_active Abandoned
- 2002-10-11 IL IL16129602A patent/IL161296A0/xx not_active IP Right Cessation
- 2002-10-11 EP EP02801405A patent/EP1446733B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US7485713B2 (en)	2009-02-03
US20050059577A1 (en)	2005-03-17
ATE442444T1 (de)	2009-09-15
DK1446733T3 (da)	2009-10-26
NZ532460A (en)	2005-10-28
PT1446733E (pt)	2009-09-28
IL161296A0 (en)	2004-09-27
JP2005505307A (ja)	2005-02-24
AU2002334161B2 (en)	2007-03-29
KR20050035511A (ko)	2005-04-18
WO2003034275A2 (en)	2003-04-24
CA2494706A1 (en)	2003-04-24
EP1446733A2 (en)	2004-08-18
EP1446733B1 (en)	2009-09-09
WO2003034275A3 (en)	2003-11-27
KR20100039911A (ko)	2010-04-16
ES2329228T3 (es)	2009-11-24
JP4384492B2 (ja)	2009-12-16
CN1568330A (zh)	2005-01-19
HUP0401611A2 (hu)	2004-11-29
HUP0401611A3 (en)	2010-01-28
DE60233674D1 (de)	2009-10-22

Legal Events

Date	Code	Title	Description
2011-03-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
YU19903A (sh)	2006-05-25	Novi receptor nukleinskih kiselina i polipeptida
IL226717A (en)	2016-04-21	Isolated nucleic acids encoded by anti-beta human antibodies 7
WO1996034107A3 (en)	1997-04-24	Antiviral proteins, dna coding sequences therefor, and uses thereof
WO2005005462A3 (en)	2006-01-26	Blys antagonists and uses thereof
WO2002089738A3 (en)	2003-04-10	Proteomimetic compounds and methods
DE69840699D1 (de)	2009-05-14	Heregulin varianten
TR200102191T2 (tr)	2001-12-21	HER-2/neu füzyon proteinleri.
CY1112101T1 (el)	2015-11-04	Νευροτροφικοι παραγοντες
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
EP0837133A3 (en)	2000-05-31	DNA strand resolution proteins of the resolvase family
EP1141286A4 (en)	2002-06-26	Cytokine receptor chain
IL161296A0 (en)	2004-09-27	Glycosylphosphatidylinositol containing polypeptides
MX9703364A (es)	1997-08-30	Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
AU7216498A (en)	1998-11-11	Inhibitors of the urokinase receptor
TR200102655T2 (tr)	2002-04-22	Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
EP0897011A3 (en)	1999-12-29	Novel arginine deiminase
WO2003018756A3 (en)	2005-03-31	Methods for preparing purified prostaglandin e synthase
GB0008252D0 (en)	2000-05-24	G protien coupled receptor
WO2002047711A3 (en)	2002-11-28	Modulators of activity of g-protein-coupled receptor kinases
DE50206254D1 (de)	2006-05-18	Pna-konjugat zur therapie der chronischen myeloischen leukämie (cml)
EP0892059A3 (en)	1999-12-22	Histidine kinase polypeptides
EP0885965A3 (en)	2000-01-12	Histidine kinase polypeptides
WO1999029719A3 (en)	1999-09-23	Pancreatic-derived factors, and uses related thereto
AU2002338854A1 (en)	2003-03-24	Methods for construction and screening of libraries of chemokine variants
WO2006040660A3 (en)	2006-06-15	Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof